PMC:7153689 / 3265-4011 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"59","span":{"begin":660,"end":668},"obj":"Disease"}],"attributes":[{"id":"A59","pred":"tao:has_database_id","subj":"59","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"A critical factor in slowing down the pandemic is the rapid diagnosis of new cases. Nucleic acid amplification tests, such as real-time reverse transcription polymerase chain reaction (RT-PCR), provide the earliest and most accurate diagnosis, but they are costly and time consuming (7). Point-of-care tests, e.g. lateral flow assays for the detection of antibodies are more ideal in the field; however, these tests are of limited value due accuracy issues and the time required to obtain a diagnosis. Rapid antigen detection tests are still undergoing evaluation, and their efficacy is yet to be proven. Figure 3 illustrates various tests being evaluated for COVID-19 and their diagnostic coverage from the acute phase to the convalescent phase."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T26","span":{"begin":660,"end":668},"obj":"Disease"}],"attributes":[{"id":"A26","pred":"mondo_id","subj":"T26","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"A critical factor in slowing down the pandemic is the rapid diagnosis of new cases. Nucleic acid amplification tests, such as real-time reverse transcription polymerase chain reaction (RT-PCR), provide the earliest and most accurate diagnosis, but they are costly and time consuming (7). Point-of-care tests, e.g. lateral flow assays for the detection of antibodies are more ideal in the field; however, these tests are of limited value due accuracy issues and the time required to obtain a diagnosis. Rapid antigen detection tests are still undergoing evaluation, and their efficacy is yet to be proven. Figure 3 illustrates various tests being evaluated for COVID-19 and their diagnostic coverage from the acute phase to the convalescent phase."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T17","span":{"begin":0,"end":1},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T18","span":{"begin":111,"end":116},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T19","span":{"begin":302,"end":307},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T20","span":{"begin":388,"end":393},"obj":"http://purl.obolibrary.org/obo/UBERON_0007688"},{"id":"T21","span":{"begin":410,"end":415},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T22","span":{"begin":489,"end":490},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T23","span":{"begin":526,"end":531},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T24","span":{"begin":634,"end":639},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"}],"text":"A critical factor in slowing down the pandemic is the rapid diagnosis of new cases. Nucleic acid amplification tests, such as real-time reverse transcription polymerase chain reaction (RT-PCR), provide the earliest and most accurate diagnosis, but they are costly and time consuming (7). Point-of-care tests, e.g. lateral flow assays for the detection of antibodies are more ideal in the field; however, these tests are of limited value due accuracy issues and the time required to obtain a diagnosis. Rapid antigen detection tests are still undergoing evaluation, and their efficacy is yet to be proven. Figure 3 illustrates various tests being evaluated for COVID-19 and their diagnostic coverage from the acute phase to the convalescent phase."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T1","span":{"begin":92,"end":96},"obj":"Chemical"},{"id":"T2","span":{"begin":508,"end":515},"obj":"Chemical"}],"attributes":[{"id":"A1","pred":"chebi_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_37527"},{"id":"A2","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_59132"}],"text":"A critical factor in slowing down the pandemic is the rapid diagnosis of new cases. Nucleic acid amplification tests, such as real-time reverse transcription polymerase chain reaction (RT-PCR), provide the earliest and most accurate diagnosis, but they are costly and time consuming (7). Point-of-care tests, e.g. lateral flow assays for the detection of antibodies are more ideal in the field; however, these tests are of limited value due accuracy issues and the time required to obtain a diagnosis. Rapid antigen detection tests are still undergoing evaluation, and their efficacy is yet to be proven. Figure 3 illustrates various tests being evaluated for COVID-19 and their diagnostic coverage from the acute phase to the convalescent phase."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T2","span":{"begin":136,"end":157},"obj":"http://purl.obolibrary.org/obo/GO_0001171"},{"id":"T3","span":{"begin":144,"end":157},"obj":"http://purl.obolibrary.org/obo/GO_0006351"}],"text":"A critical factor in slowing down the pandemic is the rapid diagnosis of new cases. Nucleic acid amplification tests, such as real-time reverse transcription polymerase chain reaction (RT-PCR), provide the earliest and most accurate diagnosis, but they are costly and time consuming (7). Point-of-care tests, e.g. lateral flow assays for the detection of antibodies are more ideal in the field; however, these tests are of limited value due accuracy issues and the time required to obtain a diagnosis. Rapid antigen detection tests are still undergoing evaluation, and their efficacy is yet to be proven. Figure 3 illustrates various tests being evaluated for COVID-19 and their diagnostic coverage from the acute phase to the convalescent phase."}

{"project":"LitCovid-sentences","denotations":[{"id":"T24","span":{"begin":0,"end":83},"obj":"Sentence"},{"id":"T25","span":{"begin":84,"end":287},"obj":"Sentence"},{"id":"T26","span":{"begin":288,"end":501},"obj":"Sentence"},{"id":"T27","span":{"begin":502,"end":604},"obj":"Sentence"},{"id":"T28","span":{"begin":605,"end":746},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"A critical factor in slowing down the pandemic is the rapid diagnosis of new cases. Nucleic acid amplification tests, such as real-time reverse transcription polymerase chain reaction (RT-PCR), provide the earliest and most accurate diagnosis, but they are costly and time consuming (7). Point-of-care tests, e.g. lateral flow assays for the detection of antibodies are more ideal in the field; however, these tests are of limited value due accuracy issues and the time required to obtain a diagnosis. Rapid antigen detection tests are still undergoing evaluation, and their efficacy is yet to be proven. Figure 3 illustrates various tests being evaluated for COVID-19 and their diagnostic coverage from the acute phase to the convalescent phase."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T35","span":{"begin":84,"end":91},"obj":"CHEBI:23447;GO:0005634;CHEBI:23447"},{"id":"T36","span":{"begin":92,"end":96},"obj":"CHEBI:37527;CHEBI:37527"},{"id":"T37","span":{"begin":136,"end":157},"obj":"GO:0001171"},{"id":"T38","span":{"begin":355,"end":365},"obj":"GO:0042571"},{"id":"T39","span":{"begin":508,"end":515},"obj":"CHEBI:59132;CHEBI:59132"},{"id":"T40","span":{"begin":660,"end":668},"obj":"SP_7"},{"id":"T41","span":{"begin":708,"end":719},"obj":"GO:0006953"},{"id":"T3553","span":{"begin":84,"end":91},"obj":"CHEBI:23447;GO:0005634;CHEBI:23447"},{"id":"T57133","span":{"begin":92,"end":96},"obj":"CHEBI:37527;CHEBI:37527"},{"id":"T47984","span":{"begin":136,"end":157},"obj":"GO:0001171"},{"id":"T42493","span":{"begin":355,"end":365},"obj":"GO:0042571"},{"id":"T14079","span":{"begin":508,"end":515},"obj":"CHEBI:59132;CHEBI:59132"},{"id":"T68472","span":{"begin":660,"end":668},"obj":"SP_7"},{"id":"T3989","span":{"begin":708,"end":719},"obj":"GO:0006953"}],"text":"A critical factor in slowing down the pandemic is the rapid diagnosis of new cases. Nucleic acid amplification tests, such as real-time reverse transcription polymerase chain reaction (RT-PCR), provide the earliest and most accurate diagnosis, but they are costly and time consuming (7). Point-of-care tests, e.g. lateral flow assays for the detection of antibodies are more ideal in the field; however, these tests are of limited value due accuracy issues and the time required to obtain a diagnosis. Rapid antigen detection tests are still undergoing evaluation, and their efficacy is yet to be proven. Figure 3 illustrates various tests being evaluated for COVID-19 and their diagnostic coverage from the acute phase to the convalescent phase."}

{"project":"2_test","denotations":[{"id":"32308536-32196430-66949961","span":{"begin":284,"end":285},"obj":"32196430"}],"text":"A critical factor in slowing down the pandemic is the rapid diagnosis of new cases. Nucleic acid amplification tests, such as real-time reverse transcription polymerase chain reaction (RT-PCR), provide the earliest and most accurate diagnosis, but they are costly and time consuming (7). Point-of-care tests, e.g. lateral flow assays for the detection of antibodies are more ideal in the field; however, these tests are of limited value due accuracy issues and the time required to obtain a diagnosis. Rapid antigen detection tests are still undergoing evaluation, and their efficacy is yet to be proven. Figure 3 illustrates various tests being evaluated for COVID-19 and their diagnostic coverage from the acute phase to the convalescent phase."}